News

Topiramate prophylaxis was linked to reduced cluster headache pain and disability in adults across this prospective cohort.

Ixekizumab achieved high clinical response rates in children with juvenile idiopathic arthritis in a Phase III trial.

Among Gen Z college students, HPV vaccination intention was driven more by vaccine perceptions than emotional flow.

STEM cell therapy is emerging as a promising approach for silicosis, an irreversible fibrotic lung disease caused by chronic exposure to respirable crystalline silica.

Abrocitinib appears durable and well tolerated in patients with moderate-to-severe atopic dermatitis (AD), also known as eczema, according to a 2-year retrospective real-world study.

A new transition success score for pediatric rheumatology patients provides a structured method to evaluate outcomes when adolescents move from pediatric to adult care.

Adaptive artificial intelligence may reshape neuroplasticity, raising concern that cognitive autonomy could be gradually compromised.

A new review has highlighted the gut microbiota as a potential systemic driver of liver metastasis in small cell lung cancer, shifting attention beyond tumor genetics alone to the gut liver axis.